Navigation Links
TB Alliance Appoints Willo Brock Senior Vice President, External Affairs
Date:7/31/2014

NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit with the mission of discovering and developing better, faster and affordable treatments, announced the appointment of Willo Brock as Senior Vice President, External Affairs. Mr. Brock comes to TB Alliance having most recently served as Head of Major Donor Relations for WWF International (formerly known as the World Wildlife Fund). In his role, Mr. Brock will guide the TB Alliance's resource development, advocacy and policy, and community and stakeholder engagement strategies, which are focused on building global support for the development of promising new treatments to fight tuberculosis (TB).

"Never before has there been greater urgency to mobilize the resources to ensure new TB treatments in the pipeline can complete their development and reach those in need," said Mel Spigelman, President and CEO of the TB Alliance. "Willo Brock has extensive experience in bringing together partners to solve the world's most intractable problems. We welcome his skills and expertise to our team."

Mr. Brock comes to the TB Alliance with nearly 20 years of experience in international development, and has worked in more than 60 countries around the world. At WWF International, he led major donor relations for the US$100 million Campaign for a Living Planet, the organization's largest fundraising initiative. Prior to that, he was Director of Resource Development and Communications for Habitat for Humanity International. Mr. Brock started his career working for the Netherlands Ministry of Development in Pakistan.

"The work done by TB Alliance and its partners has the potential to save millions of lives, with a number of vitally important TB treatments that are very close to the finish line," said Willo Brock. "This is an opportunity to have an immediate impact on the lives of people in resource-poor nations."

Mr. Brock is a native of The Netherlands and holds a Masters of Business Administration from the Rotterdam School of Business at Erasmus University.

Every year, 1.3 million people worldwide die from TB. It is estimated that the bacteria that causes TB infects one-third of the world's population. The current treatment is inadequate, and resistance to today's drugs is growing. New, faster-acting, simpler drug regimens are critical to defeating TB.

About the TB Alliance

The Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis. Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. The TB Alliance operates with funding from Australia Department of Foreign Affairs and Trade, Bill & Melinda Gates Foundation, European Commission, Global Health Innovative Technology Fund, Irish Aid, National Institute of Allergy and Infectious Disease, UNITAID, United Kingdom Department for International Development, United States Agency for International Development, and the United States Food and Drug Administration. For more information, please visit tballiance.org.

Contact:
Joanna Breitstein, +1 646-616-8613 or joanna.breitstein@tballiance.org

Photo - http://photos.prnewswire.com/prnh/20140730/131795


'/>"/>
SOURCE TB Alliance
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Columbia Laboratories Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis
2. Advinus Therapeutics, a TATA Enterprise, Meets Year 1 Milestone in Drug Discovery Alliance
3. New White Paper from Tuberous Sclerosis Alliance Assesses Visual Field Risks of Vigabatrin
4. Millennium Pharmacy Systems, Inc. SVP Pharmacy Operations & Chief Compliance Officer Appointed to 2014 Pharmacy Quality Alliance Board
5. Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials
6. Maverix Biomics Forms Strategic Co-Marketing Alliance with QIAGEN
7. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
8. Strategic Alliance Formed to Fight Counterfeit Drugs
9. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
10. Physician-Patient Alliance for Health & Safety: Maternal Morbidity on the Rise and Likely to Climb Even Higher
11. The Pershing Square Foundation Partners with The Sohn Conference Foundation To Launch $25 Million Cancer Research Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition ... their offering. ... The global lifestyle drugs market to grow at a CAGR of ... Lifestyle Drugs Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
(Date:3/29/2017)... , March 29, 2017  Designers of primary cell ... solution size by 50% and extend battery life with ... management integrated circuit (PMIC) from Maxim Integrated Products, Inc. ... a low input voltage of just 0.7V for new ... Silver Oxide, as well as the more common Alkaline ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... The Wall Centre Dental team ... patients from Burnaby, BC. Patients in need of experienced orthodontics, laser dentistry, porcelain ... the esteemed team at Wall Centre Dental. Drs. Parviz Roshan, Siamak Tehrani, Milton ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... developing an ANSI-approved, consensus-based American National Standard for Good Manufacturing Practices (GMPs) ... first ANSI-approved GMP standard for dietary supplements this spring, is hiring an ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... ... hassles associated with wearing oral braces. "The rubber bands used in conjunction with ... said, "so I decided to design a way to prevent this problem." The ...
(Date:3/29/2017)... ... 29, 2017 , ... Hamlin Dental Group, multi-location dental office in North ... Dental lasers are safe and effective options, and can be used alone or in ... overall quality of care. , Dr. Hamid Reza of Hamlin Dental Group offers other ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... AvePoint ... seventh North American office location in Richmond, Virginia, located at the Riverfront Plaza, 901 ... attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond Levar ...
Breaking Medicine News(10 mins):